NVCHI
MED icon

New Vernon Capital Holdings II’s Medifast MED Stock Holding History

New Vernon Capital Holdings II’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,087
Closed -$118K – 85
2024
Q1 		$118K Hold
3,087
– – 0.06% 66
2023
Q4 		$208K Buy
3,087
+728
+31% +$50.7K 0.11% 68
2023
Q3 		$177K Buy
+2,359
New +$209K 0.15% 56
2023
Q2 		– Sell
-1,193
Closed -$124K – 85
2023
Q1 		$124K Buy
1,193
+17
+1% +$1.88K 0.09% 78
2022
Q4 		$136K Buy
1,176
+343
+41% +$39.9K 0.11% 73
2022
Q3 		$90K Sell
833
-1,197
-59% -$172K 0.09% 57
2022
Q2 		$366K Buy
+2,030
New +$363K 0.3% 17

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

New Vernon Capital Holdings II's MED Position: Q2 2024 in Review

New Vernon Capital Holdings II sold out of Medifast (MED) in Q2 2024, closing a stake of 3,087 shares — an estimated $118K sold.

New Vernon Capital Holdings II first reported a position in MED in Q2 2022 and held it in 7 quarters. The position peaked at $366K in Q2 2022. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • New Vernon Capital Holdings II reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 3,087 Medifast shares in Q2 2024, an estimated $118K.
  • New Vernon Capital Holdings II first reported a position in Medifast in Q2 2022 and held it in 7 quarters.
  • New Vernon Capital Holdings II's Medifast position peaked at $366K in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q2 2024, filed 14 Aug 2024.